These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
679 related articles for article (PubMed ID: 12089450)
21. Identification of a functional epitope of the Nogo receptor by a combinatorial approach using ribosome display. Schimmele B; Plückthun A J Mol Biol; 2005 Sep; 352(1):229-41. PubMed ID: 16061255 [TBL] [Abstract][Full Text] [Related]
22. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322 [TBL] [Abstract][Full Text] [Related]
23. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. Mehta NR; Lopez PH; Vyas AA; Schnaar RL J Biol Chem; 2007 Sep; 282(38):27875-86. PubMed ID: 17640868 [TBL] [Abstract][Full Text] [Related]
24. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. Venkatesh K; Chivatakarn O; Lee H; Joshi PS; Kantor DB; Newman BA; Mage R; Rader C; Giger RJ J Neurosci; 2005 Jan; 25(4):808-22. PubMed ID: 15673660 [TBL] [Abstract][Full Text] [Related]
25. Nogo on the go. McKerracher L; Winton MJ Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839 [TBL] [Abstract][Full Text] [Related]
26. Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. Liao H; Duka T; Teng FY; Sun L; Bu WY; Ahmed S; Tang BL; Xiao ZC J Neurochem; 2004 Sep; 90(5):1156-62. PubMed ID: 15312170 [TBL] [Abstract][Full Text] [Related]
27. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. McGee AW; Strittmatter SM Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770 [TBL] [Abstract][Full Text] [Related]
28. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members. Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258 [TBL] [Abstract][Full Text] [Related]
29. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand. Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269 [TBL] [Abstract][Full Text] [Related]
30. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357 [TBL] [Abstract][Full Text] [Related]
31. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. Barton WA; Liu BP; Tzvetkova D; Jeffrey PD; Fournier AE; Sah D; Cate R; Strittmatter SM; Nikolov DB EMBO J; 2003 Jul; 22(13):3291-302. PubMed ID: 12839991 [TBL] [Abstract][Full Text] [Related]
32. TACE-induced cleavage of NgR and p75NTR in dorsal root ganglion cultures disinhibits outgrowth and promotes branching of neurites in the presence of inhibitory CNS myelin. Ahmed Z; Mazibrada G; Seabright RJ; Dent RG; Berry M; Logan A FASEB J; 2006 Sep; 20(11):1939-41. PubMed ID: 16849393 [TBL] [Abstract][Full Text] [Related]
34. Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor. Walmsley AR; McCombie G; Neumann U; Marcellin D; Hillenbrand R; Mir AK; Frentzel S J Cell Sci; 2004 Sep; 117(Pt 19):4591-602. PubMed ID: 15331667 [TBL] [Abstract][Full Text] [Related]
35. Differential expression patterns of messenger RNAs encoding Nogo receptors and their ligands in the rat central nervous system. Funahashi S; Hasegawa T; Nagano A; Sato K J Comp Neurol; 2008 Jan; 506(1):141-60. PubMed ID: 17990276 [TBL] [Abstract][Full Text] [Related]
36. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface. Saha N; Kolev M; Nikolov DB Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133 [TBL] [Abstract][Full Text] [Related]
37. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. Li S; Strittmatter SM J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems. Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405 [TBL] [Abstract][Full Text] [Related]
39. Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein. DeBellard ME; Tang S; Mukhopadhyay G; Shen YJ; Filbin MT Mol Cell Neurosci; 1996 Feb; 7(2):89-101. PubMed ID: 8731478 [TBL] [Abstract][Full Text] [Related]
40. Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways. Palandri A; Salvador VR; Wojnacki J; Vivinetto AL; Schnaar RL; Lopez PH Cell Death Dis; 2015 Sep; 6(9):e1876. PubMed ID: 26335717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]